Tague, Laneshia K <br/><br/>
Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.  [electronic resource] 

 -  The pharmacogenomics journal  02 2020 
 - 69-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/s41397-019-0086-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Allografts--drug effects<br/>Azathioprine--administration & dosage<br/>Female<br/>Genotype<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Lung--metabolism<br/>Lung Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Multidrug Resistance-Associated Proteins--genetics<br/>Mycophenolic Acid--administration & dosage<br/>Polymorphism, Single Nucleotide--genetics<br/>Solute Carrier Organic Anion Transporter Family Member 1B3--genetics<br/>Transplant Recipients